U.S. markets closed

Provident Financial Services, Inc. (PFS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
22.52+1.74 (+8.37%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close20.78
Open21.45
Bid16.51 x 1400
Ask22.61 x 800
Day's Range21.38 - 22.76
52 Week Range9.05 - 22.76
Volume689,672
Avg. Volume357,381
Market Cap1.752B
Beta (5Y Monthly)1.04
PE Ratio (TTM)16.20
EPS (TTM)1.39
Earnings DateApr 28, 2021 - May 03, 2021
Forward Dividend & Yield0.92 (4.09%)
Ex-Dividend DateFeb 11, 2021
1y Target Est20.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-29% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021

    Upgrades For Boeing Co (NYSE:BA), Canaccord Genuity upgraded the previous rating of Hold to Buy. In the fourth quarter, Boeing showed an EPS of $4.21, compared to $2.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $285.91 and a 52-week-low of $89.00. Boeing closed at $224.95 at the end of the last trading period. For Seres Therapeutics Inc (NASDAQ:MCRB), Chardan Capital upgraded the previous rating of Neutral to Buy. For the fourth quarter, Seres Therapeutics had an EPS of $0.19, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $38.50 and a 52-week-low of $2.52. At the end of the last trading period, Seres Therapeutics closed at $18.11. Truist Securities upgraded the previous rating for NextCure Inc (NASDAQ:NXTC) from Hold to Buy. NextCure earned $0.56 in the fourth quarter, compared to $0.34 in the year-ago quarter. The stock has a 52-week-high of $44.71 and a 52-week-low of $7.91. At the end of the last trading period, NextCure closed at $11.39. Barclays upgraded the previous rating for Oracle Corp (NYSE:ORCL) from Equal-Weight to Overweight. For the second quarter, Oracle had an EPS of $1.06, compared to year-ago quarter EPS of $0.90. The stock has a 52-week-high of $67.54 and a 52-week-low of $39.71. At the end of the last trading period, Oracle closed at $65.60. For Limoneira Co (NASDAQ:LMNR), Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Limoneira showed an EPS of $0.42, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $17.84 and a 52-week-low of $10.60. At the end of the last trading period, Limoneira closed at $15.84. According to B of A Securities, the prior rating for Cardlytics Inc (NASDAQ:CDLX) was changed from Underperform to Neutral. Cardlytics earned $0.05 in the fourth quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $161.47 and a 52-week-low of $27.33. At the end of the last trading period, Cardlytics closed at $126.02. For Azul SA (NYSE:AZUL), Deutsche Bank upgraded the previous rating of Hold to Buy. In the fourth quarter, Azul showed an EPS of $0.28, compared to $0.23 from the year-ago quarter. The stock has a 52-week-high of $30.41 and a 52-week-low of $5.30. At the end of the last trading period, Azul closed at $20.34. For SBA Communications Corp (NASDAQ:SBAC), Raymond James upgraded the previous rating of Outperform to Strong Buy. In the fourth quarter, SBA Communications showed an EPS of $0.94, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $328.37 and a 52-week-low of $205.20. SBA Communications closed at $235.92 at the end of the last trading period. For Ballys Corp (NYSE:BALY), Stifel upgraded the previous rating of Hold to Buy. For the fourth quarter, Ballys had an EPS of $0.39, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $66.97 and a 52-week-low of $29.30. Ballys closed at $52.29 at the end of the last trading period. DZ Bank upgraded the previous rating for Exxon Mobil Corp (NYSE:XOM) from Sell to Hold. In the fourth quarter, Exxon Mobil showed an EPS of $0.03, compared to $0.41 from the year-ago quarter. The current stock performance of Exxon Mobil shows a 52-week-high of $59.47 and a 52-week-low of $30.11. Moreover, at the end of the last trading period, the closing price was at $58.67. For Provident Financial Services Inc (NYSE:PFS), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Provident Financial earned $0.56 in the fourth quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.30 and a 52-week-low of $9.05. Provident Financial closed at $20.76 at the end of the last trading period. JP Morgan upgraded the previous rating for Cisco Systems Inc (NASDAQ:CSCO) from Neutral to Overweight. For the second quarter, Cisco Systems had an EPS of $0.79, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $49.34 and a 52-week-low of $32.40. Cisco Systems closed at $44.56 at the end of the last trading period. According to JP Morgan, the prior rating for Darling Ingredients Inc (NYSE:DAR) was changed from Neutral to Overweight. For the fourth quarter, Darling Ingredients had an EPS of $0.45, compared to year-ago quarter EPS of $0.92. The current stock performance of Darling Ingredients shows a 52-week-high of $72.85 and a 52-week-low of $10.25. Moreover, at the end of the last trading period, the closing price was at $67.95. According to Jefferies, the prior rating for Paycom Software Inc (NYSE:PAYC) was changed from Hold to Buy. In the fourth quarter, Paycom Software showed an EPS of $0.84, compared to $0.86 from the year-ago quarter. The current stock performance of Paycom Software shows a 52-week-high of $471.08 and a 52-week-low of $163.42. Moreover, at the end of the last trading period, the closing price was at $349.44. According to Morgan Stanley, the prior rating for The Michaels Companies Inc (NASDAQ:MIK) was changed from Underweight to Equal-Weight. Michaels Companies earned $1.69 in the fourth quarter, compared to $1.26 in the year-ago quarter. The current stock performance of Michaels Companies shows a 52-week-high of $22.30 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $21.83. See all analyst ratings upgrades. Downgrades Craig-Hallum downgraded the previous rating for Smith & Wesson Brands Inc (NASDAQ:SWBI) from Buy to Hold. Smith & Wesson Brands earned $0.93 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Smith & Wesson Brands shows a 52-week-high of $27.79 and a 52-week-low of $12.87. Moreover, at the end of the last trading period, the closing price was at $15.79. For Transocean Ltd (NYSE:RIG), Barclays downgraded the previous rating of Equal-Weight to Underweight. In the fourth quarter, Transocean showed an EPS of $0.34, compared to $0.43 from the year-ago quarter. The current stock performance of Transocean shows a 52-week-high of $4.24 and a 52-week-low of $0.65. Moreover, at the end of the last trading period, the closing price was at $4.11. Barclays downgraded the previous rating for Frank's International NV (NYSE:FI) from Equal-Weight to Underweight. In the fourth quarter, Frank's International showed an EPS of $0.02, compared to $0.06 from the year-ago quarter. The current stock performance of Frank's International shows a 52-week-high of $5.44 and a 52-week-low of $1.49. Moreover, at the end of the last trading period, the closing price was at $4.88. According to Barclays, the prior rating for Dril-Quip Inc (NYSE:DRQ) was changed from Equal-Weight to Underweight. Dril-Quip earned $0.12 in the fourth quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $38.72 and a 52-week-low of $22.25. At the end of the last trading period, Dril-Quip closed at $37.13. Loop Capital downgraded the previous rating for The Michaels Companies Inc (NASDAQ:MIK) from Buy to Hold. For the fourth quarter, Michaels Companies had an EPS of $1.69, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $22.30 and a 52-week-low of $1.00. At the end of the last trading period, Michaels Companies closed at $21.83. For Senseonics Holdings Inc (AMEX:SENS), Raymond James downgraded the previous rating of Market Perform to Underperform. In the fourth quarter, Senseonics Holdings showed an EPS of $0.44, compared to $0.18 from the year-ago quarter. The current stock performance of Senseonics Holdings shows a 52-week-high of $5.56 and a 52-week-low of $0.35. Moreover, at the end of the last trading period, the closing price was at $2.69. For Nikola Corp (NASDAQ:NKLA), JP Morgan downgraded the previous rating of Overweight to Neutral. For the fourth quarter, Nikola had an EPS of $0.17, compared to year-ago quarter EPS of $0.09. The current stock performance of Nikola shows a 52-week-high of $93.99 and a 52-week-low of $13.51. Moreover, at the end of the last trading period, the closing price was at $16.03. According to Jefferies, the prior rating for Five Prime Therapeutics Inc (NASDAQ:FPRX) was changed from Buy to Hold. Five Prime Therapeutics earned $0.74 in the third quarter, compared to $1.03 in the year-ago quarter. The current stock performance of Five Prime Therapeutics shows a 52-week-high of $38.18 and a 52-week-low of $1.75. Moreover, at the end of the last trading period, the closing price was at $38.00. See all analyst ratings downgrades. Initiations With a Buy rating, Stifel initiated coverage on DZS Inc (NASDAQ:DZSI). The price target seems to have been set at $22.00 for DZS. The stock has a 52-week-high of $18.90 and a 52-week-low of $2.90. At the end of the last trading period, DZS closed at $15.78. With an Outperform rating, RBC Capital initiated coverage on Viemed Healthcare Inc (NASDAQ:VMD). The price target seems to have been set at $13.00 for Viemed Healthcare. In the fourth quarter, Viemed Healthcare showed an EPS of $0.12, compared to $0.06 from the year-ago quarter. The current stock performance of Viemed Healthcare shows a 52-week-high of $11.98 and a 52-week-low of $2.44. Moreover, at the end of the last trading period, the closing price was at $9.70. With an Outperform rating, Evercore ISI Group initiated coverage on Cognyte Software Ltd (NASDAQ:CGNT). The price target seems to have been set at $40.00 for Cognyte Software. The stock has a 52-week-high of $33.50 and a 52-week-low of $23.75. At the end of the last trading period, Cognyte Software closed at $27.32. With an Outperform rating, CICC initiated coverage on UP Fintech Holding Ltd (NASDAQ:TIGR). The price target seems to have been set at $30.60 for UP Fintech Holding. In the first quarter, UP Fintech Holding showed an EPS of $0.04, compared to $0.01 from the year-ago quarter. The current stock performance of UP Fintech Holding shows a 52-week-high of $38.50 and a 52-week-low of $2.03. Moreover, at the end of the last trading period, the closing price was at $20.33. Baird initiated coverage on Asana Inc (NYSE:ASAN) with an Outperform rating. The price target for Asana is set to $40.00. Interestingly, in the third quarter, Asana's EPS was $0.34. At the moment, the stock has a 52-week-high of $43.72 and a 52-week-low of $20.57. Asana closed at $30.64 at the end of the last trading period. With a Buy rating, HC Wainwright & Co. initiated coverage on Milestone Pharmaceuticals Inc (NASDAQ:MIST). The price target seems to have been set at $20.00 for Milestone Pharmaceuticals. Milestone Pharmaceuticals earned $0.40 in the third quarter, compared to $0.52 in the year-ago quarter. The stock has a 52-week-high of $20.75 and a 52-week-low of $1.69. At the end of the last trading period, Milestone Pharmaceuticals closed at $6.52. With a Buy rating, HC Wainwright & Co. initiated coverage on Aqua Metals Inc (NASDAQ:AQMS). The price target seems to have been set at $8.00 for Aqua Metals. Aqua Metals earned $0.05 in the fourth quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $8.06 and a 52-week-low of $0.33. At the end of the last trading period, Aqua Metals closed at $3.54. See all analyst ratings initiations. Latest Ratings for BA DateFirmActionFromTo Mar 2021Canaccord GenuityUpgradesHoldBuy Mar 2021Morgan StanleyMaintainsOverweight Jan 2021Morgan StanleyUpgradesUnderweightOverweight View More Analyst Ratings for BA View the Latest Analyst Ratings See more from BenzingaClick here for options trades from BenzingaWhy Seres Therapeutics's Stock is Trading Lower TodayUnderstanding Oracle's Unusual Options Activity© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Provident Financial Services' (NYSE:PFS) Shareholders Are Down 24% On Their Shares
    Simply Wall St.

    Provident Financial Services' (NYSE:PFS) Shareholders Are Down 24% On Their Shares

    While it may not be enough for some shareholders, we think it is good to see the Provident Financial Services, Inc...

  • Top Ranked Income Stocks to Buy for February 3rd
    Zacks

    Top Ranked Income Stocks to Buy for February 3rd

    Top Ranked Income Stocks to Buy for February 3rd